NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cannabics Pharmaceuticals Inc (OTCQB: CNBX)

 
CNBX Technical Analysis
5
As on 9th Jun 2023 CNBX STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.37 & Strong Sell for SHORT-TERM with Stoploss of 0.10 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CNBXSTOCK Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 300486 1 Year -0.10 -83.33
52 Week High 9.91 | 52 Week Low 0.01
 
OTCQB USA Most Active Stocks
BMIX 0.01 %
MOBQ 0.18 -5.26%
FNMA 0.45 0.00%
ALPP 3.56 -0.80%
ALPP 3.56 -0.80%
SHMP 0.06 0.00%
NWBO 0.73 0.00%
VPLM 0.08 %
NLST 3.72 -8.60%
SRNA 2.78 14.88%
 
OTCQB USA Top Gainers Stocks
EMMLF 0.89 8800.00%
EWLUD 0.45 275.00%
RASP 0.03 200.00%
RASP 0.03 200.00%
SSEBF 0.02 100.00%
NVAAF 0.40 100.00%
PWWBF 0.02 100.00%
HCAND 0.02 100.00%
SIXWF 0.02 100.00%
IPCIF 0.06 100.00%
 
OTCQB USA Top Losers Stocks
LKMNF 0.01 -50.00%
ALDS 0.01 -50.00%
GMGT 0.03 -50.00%
BNKL 0.60 -39.39%
PPCB 0.05 -37.50%
ATAO 0.09 -35.71%
FCIC 0.38 -34.48%
PKTX 0.02 -33.33%
MNTR 0.02 -33.33%
MNTR 0.02 -33.33%
 
 
CNBX
Daily Charts
CNBX
Intraday Charts
Whats New @
Bazaartrend
CNBX
Free Analysis
 
CNBX Important Levels Intraday
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
RESISTANCE0.02
 
CNBX Forecast April 2024
4th UP Forecast0.1
3rd UP Forecast0.07
2nd UP Forecast0.06
1st UP Forecast0.04
1st DOWN Forecast0
2nd DOWN Forecast-0.02
3rd DOWN Forecast-0.03
4th DOWN Forecast-0.06
 
CNBX Weekly Forecast
4th UP Forecast0.12
3rd UP Forecast0.09
2nd UP Forecast0.07
1st UP Forecast0.05
1st DOWN Forecast-0.01
2nd DOWN Forecast-0.03
3rd DOWN Forecast-0.05
4th DOWN Forecast-0.08
 
CNBX Forecast2024
4th UP Forecast20.81
3rd UP Forecast14.14
2nd UP Forecast10.02
1st UP Forecast5.9
1st DOWN Forecast-5.86
2nd DOWN Forecast-9.98
3rd DOWN Forecast-14.1
4th DOWN Forecast-20.77
 
 
CNBX Other Details
Segment EQ
Market Capital 21823156.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CNBX Address
CNBX
 
CNBX Latest News
 
Your Comments and Response on Cannabics Pharmaceuticals Inc
 
CNBX Business Profile
Cannabics Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. The company focuses on developing and marketing bioinformatic delivery systems for cannabinoids, personalized medicine therapies, and procedures based on cannabis originated compounds and bioinformatics tools. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, a drug sensitivity test for cannabinoid-based cancer therapies. The company was formerly known as American Mining Corporation and changed its name to Cannabics Pharmaceuticals Inc. in May 2014. Cannabics Pharmaceuticals Inc. was founded in 2004 and is based in Bethesda, Maryland. Cannabics Pharmaceuticals Inc. is a subsidiary of Cannabics Inc. Address: #3 Bethesda Metro Center, Bethesda, MD, United States, 20814
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service